Form 4: USPH Director Nancy Ham Sells Shares Under 10b5-1 Plan
Insider Transaction Report
U.S. Physical Therapy Director Nancy Ham sold 600 shares of common stock at $81.71 per share, as disclosed in a recent SEC Form 4 filing.
Summary
- Nancy Ham, a Director of U.S. Physical Therapy Inc. (USPH), reported the sale of 600 shares of common stock.
- The transaction occurred on September 11, 2025, at a price of $81.71 per share.
- Following this transaction, Ms. Ham beneficially owns 1,994 shares of common stock directly.
- The reported transaction was made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan.
- The remaining 1,994 shares include 941 restricted shares granted under the Company's Amended and Restated 2003 Stock Incentive Plan.
- Restrictions on 470 of these shares will lapse on November 20, 2025, and on the remaining 471 shares on March 6, 2026, provided Ms. Ham remains a director on those dates.
Sentiment
Score: 5
Explanation: The sentiment is neutral to slightly negative. While a director selling shares can be viewed negatively, the transaction was pre-planned under a 10b5-1 plan, which mitigates concerns about opportunistic insider selling.
Positives
- The transaction was executed under a Rule 10b5-1(c) plan, indicating a pre-scheduled sale designed to comply with insider trading regulations and potentially for personal financial planning or diversification.
Negatives
- A director's sale of common stock, even if pre-planned, can sometimes be perceived by investors as a lack of confidence in the company's near-term prospects, although this is not explicitly stated in the filing.
Industry Context
This filing reports an individual insider transaction and does not provide broader industry context or trends.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Policy Adherence | The transaction was conducted under a Rule 10b5-1(c) plan, demonstrating adherence to corporate governance best practices for insider trading. | 09/11/2025 | Enhances transparency and reduces the perception of opportunistic insider trading. |
Stakeholder Impact
- Shareholders may interpret the director's sale as a signal, though the 10b5-1 plan suggests it is for personal financial management rather than a reflection of company performance.
Next Steps
- Vesting of remaining restricted shares on November 20, 2025, and March 6, 2026, contingent on continued directorship.
Key Dates
| Date | Description |
|---|---|
| 09/11/2025 | Date of common stock transaction (sale). |
| 11/20/2025 | Restrictions lapse on 470 restricted shares, contingent on director status. |
| 03/06/2026 | Restrictions lapse on 471 restricted shares, contingent on director status. |
Keywords
USPH, U.S. Physical Therapy, Nancy Ham, Director, Stock Sale, Insider Transaction, Form 4, 10b5-1 Plan, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.